Article Details

Morphic joins May biotech IPO push with $86M goal

Retrieved on: 2019-05-30 23:00:00

Tags for this article:

Click the tags to see associated articles and topics

Morphic joins May biotech IPO push with $86M goal. View article details on hiswai:

Excerpt

<div>... was built around science from Harvard immunologist Tim Springer, who co-founded the company along with local investment firm <b>Polaris Partners</b>.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up